LOS ANGELESâ (BUSINESS WIRE) – Glancy Prongay & Murray LLP (âGPMâ), a leading national shareholder rights law firm, today announced it has opened an investigation on behalf of CareDx, Inc. ( âCareDxâ or the âCompanyâ) (NASDAQ: CDNA) investors regarding possible violations by the Company of federal securities laws.
If you have suffered a loss on your CareDx investments or would like to inquire about the possibility of pursuing claims to recover your loss under federal securities laws, you can submit your details at https: // www.glancylaw.com/cases/caredx-inc /. You can also contact Charles H. Linehan of GPM at 310-201-9150, toll-free at 888-773-9224, or by emailing [email protected] to learn more about your rights.
On October 28, 2021, after the market closed, CareDx revealed that it had received a request for a civil investigation from the US Department of Justice in connection with an investigation into “business practices related to [its] kidney testing and phlebotomy services. The Company had also received a subpoena from the United States Securities and Exchange Commission (âSECâ) for similar matters as well as certain accounting and public reporting practices.
Following this news, the Company’s share price fell $ 19.34, or 27%, to close at $ 51.00 per share on October 29, 2021, hurting investors.
Follow us for updates on LinkedIn, Twitter, or Facebook.
Notice of denunciation: Those with non-public information regarding CareDx should consider their options to facilitate the investigation or take advantage of the SEC’s whistleblower program. Under the program, whistleblowers who provide original information can receive rewards totaling up to 30 percent of any successful recovery performed by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected]
Glancy Prongay & Murray LLP is a leading law firm that represents investors and consumers in securities litigation and other complex class actions. ISS Securities Class Action Services has consistently ranked GPM in its annual SCAS Top 50 report. In 2018, GPM was ranked among the top five law firms for the number of securities class action settlements and among the top six law firms. ‘lawyers for the total size of settlements in dollars. With four offices across the country, nearly 40 GPM attorneys have won groundbreaking decisions and recouped billions of dollars for investors and consumers in securities, antitrust, consumer and employment class actions. GPM lawyers have dealt with cases covering a wide range of professional misconduct, including cases involving financial restatements, internal control weaknesses, profit management, fraudulent profit claims and forward-looking statements, auditor misconduct , insider trading, violations of FDA regulations, actions resulting in FDA and DOJ investigations, and many other forms of malpractice. GPM attorneys have worked on securities cases involving nearly all industries and sectors of the financial markets, including energy, consumer discretionary, consumer staples, real estate and REITs, finance, insurance, information technology, healthcare, biotechnology, cryptocurrency, medical devices, and many more. GPM’s past successes have been covered extensively by major news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Business Week, Reuters, the Associated press, Barron, Daily Investor Affairs, Forbes, and Money.
This press release may be considered an attorney’s advertisement in certain jurisdictions under applicable law and ethical rules.
Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, California 90067